Clinical trial
Topiramate vs. Placebo in Preventing Weight Gain in Bipolar Disorder Treated…
NCT00394095 · University of Cincinnati, Other · Completed
Key facts
| NCT number | NCT00394095 |
|---|---|
| Title | Topiramate vs. Placebo in Preventing Weight Gain in Bipolar Disorder Treated With Olanzapine |
| Official title | A Double-Blind, Randomized, Placebo-Controlled, Pilot Study of Topiramate vs. Placebo in Combination With Olanzapine for the Prevention of Weight Gain in Manic or Mixed Youth With Bipolar Disorder |
| Lead sponsor | University of Cincinnati, Other |
| Collaborators | Eli Lilly and Company Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Bipolar Disorder, Weight Gain |
| Intervention type | Drug |
| Interventions | Topiramate, Placebo |
| Enrollment | 31 |
| Start date | Dec 1, 2006 |
| Primary completion | Aug 1, 2009 |
| Completion | Sep 1, 2009 |
| First posted | Oct 31, 2006 |
| Last update posted | Apr 9, 2025 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: